NCT00553319View on ClinicalTrials.gov

Study of Adderall-XR for the Treatment of Adult Attention Deficit Hyperactivity Disorder and Cocaine Dependence

PHASE2/PHASE3CompletedINTERVENTIONAL

Enrollment

139

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

July 31, 2013

Study Completion Date

July 31, 2013

Conditions

Adult Attention Deficit Hyperactivity DisorderCocaine Dependence

Interventions

DRUG

Placebo

Placebo group

DRUG

Adderall-XR

Adderall-XR 60mg/day

DRUG

Adderall-XR

Adderall-XR 80mg/day

Trial Locations (2)

10032

STARS, New York

55454

Ambulatory Research Center/Fairview University Psychiatry Dept, Minneapolis

All Listed Sponsors

collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

New York State Psychiatric Institute

OTHER

NCT00553319 - Study of Adderall-XR for the Treatment of Adult Attention Deficit Hyperactivity Disorder and Cocaine Dependence | Biotech Hunter | Biotech Hunter